000			03325nam a22004575i 4500
999			_c383722 _d383722
001			383722
003			ES-MaUEC
005			20230102122144.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			201207s2021 si | s |||| 0|eng d
020			_a9789811584237
024	7		_a10.1007/978-981-15-8423-7 _2doi
040			_bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC270.3 .T65 _b2021 EB
245	0	0	_aApplications of FDG PET in Oncology : _bBest Clinical Practice _cedited by Hirofumi Fujii, Hiroyuki Nakamura, Seiei Yasuda
250			_a1st edition 2021
264		1	_aSingapore _bSpringer International Publishing _c2021
300			_a1 recurso en línea (VII, 147 páginas) _b61 ilustraciones, 55 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aarchivo de texto _bPDF
505	0		_a1 Overview.-2 Lung cancer.-3 Breast cancer -- 4 Head and neck cancer.-5 Gastrointestinal cancer including GIST -- 6 Pancreatic cancer -- 7 Urological cancer -- 8 Malignant bone and soft tissue tumors -- 9 Skin cancer including malignant melanoma -- 10 Malignant lymphoma.
520	3		_aThis book provides up-to-date guidance on the use of FDG PET to assess the biological activity and treatment response of a wide range of malignancies, including, for example, lung cancer, breast cancer, head and neck cancer, gastrointestinal cancer, and malignant lymphoma. In the era of precision medicine, numerous new anticancer agents, such as molecular targeted agents and immune checkpoint inhibitors, have been developed to improve outcomes in cancer patients. FDG PET plays a key role in evaluating the effects of these novel treatments because it can detect changes in the metabolic activity of tumors before any reduction in their size is visible on other imaging modalities. Accordingly, FDG PET is of prognostic as well as diagnostic value, and allows prompt changes in patient management. The book is written by expert clinicians from Japan, where the universal public health insurance system ensures that FDG PET is widely used in routine oncological practice and cancer screening. It represents an unrivaled and comprehensive resource that will be of value for all healthcare professionals in the field of clinical oncology.
988			_aSpringer_Medicine_2021
650		7	_2embne _9159703 _aTomografía por emisión
650		7	_2embne _9392696 _aCáncer _xTomografía
650		7	_2embne _9139207 _aOncología
700	1		_aFujii, Hirofumi _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aNakamura, Hiroyuki _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aYasuda, Seiei _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9789811584220
776	0	8	_iPrinted edition: _z9789811584244
776	0	8	_iPrinted edition: _z9789811584251
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-15-8423-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b11/2022 _dz _eu _zSI